Renal Cancer - Results from #3220

ACAT1 and Metabolism-Related Pathways Are Essential for the Progression of Clear Cell Renal Cell Carcinoma (ccRCC), as Determined by Co-expression Network Analysis. November 6, 2019

Monosomy of Chromosome 9 Is Associated With Higher Grade, Advanced Stage, and Adverse Outcome in Clear-cell Renal Cell Carcinoma. November 6, 2019

Is partial nephrectomy worthwhile over radical nephrectomy for localised renal cortical tumours less than 7 cm in geriatric patients? November 6, 2019

Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma. November 5, 2019

Impact of Patients' Gender on Efficacy of Immunotherapy in Patients With Metastatic Kidney Cancer: A Systematic Review and Meta-analysis. November 5, 2019

Expression of Ring Box-1 protein and its relationship with Fuhrman grade and other clinical-pathological parameters in renal cell cancer. November 5, 2019

Stereotactic body radiation therapy in combination with systemic therapy for metastatic renal cell carcinoma: a prospective multicentre study. November 4, 2019

Negative Effect of Immediate Sunitinib Interruption on Survival in Patients With Metastatic Renal Cell Carcinoma. November 4, 2019

Survival Outcomes After Adding Stereotactic Body Radiotherapy to Metastatic Renal Cell Carcinoma Patients Treated With Tyrosine Kinase Inhibitors. November 4, 2019

Clinical utility of contrast-enhanced ultrasonography in the diagnosis of benign and malignant small renal masses among Asian population. November 1, 2019

Safe use of nivolumab in a patient with renal cell carcinoma and hepatitis B. November 1, 2019

Prognostic value of the albumin-to-alkaline phosphatase ratio on urologic outcomes in patients with non-metastatic renal cell carcinoma following curative nephrectomy. November 1, 2019

Five decades of urologic pathology: the accelerating expansion of knowledge in renal cell neoplasia. October 31, 2019

Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma. October 31, 2019

Programmed Death Ligand 1; An Immunotarget for Renal Cell Carcinoma. October 31, 2019

Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trial. October 31, 2019

Cytoreductive nephrectomy in the current treatment algorithm. October 31, 2019

OSSMAR: An Observational Study to Describe the Use of Sunitinib in Real-Life Practice for the Treatment of Metastatic Renal Cell Carcinoma. October 31, 2019

Augmenting the randomized controlled trial with real-world data to aid clinical decision making in metastatic renal cell carcinoma: a systematic review and meta-analysis. October 30, 2019

The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer. October 30, 2019

Page 162 of 457